HKPD (Cellyan Biotechnology Co) Insider Ownership: 0.00 % (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKPD Cellyan Biotechnology Co Ltd HKPD
18 GF Score
Price $0.12
! 4 Warning Signs
View Full Analysis

What is Cellyan Biotechnology Co Insider Ownership?

Cellyan Biotechnology Co HKPD +3.65% 18 Insider Ownership is 0.00 % as of Sep. 12, 2026. GuruFocus rates HKPD with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cellyan Biotechnology Co's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cellyan Biotechnology Co's Institutional Ownership is 0.51%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cellyan Biotechnology Co's Float Percentage Of Total Shares Outstanding is 67.28%.

Cellyan Biotechnology Co Insider Ownership Historical Data

* Premium members only.

The historical data trend for Cellyan Biotechnology Co's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellyan Biotechnology Co Insider Ownership Chart

Cellyan Biotechnology Co Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Insider Ownership
0.00 0.00 0.00 0.00

Cellyan Biotechnology Co Semi-Annual Data
Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Insider Ownership Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKPD
18GF Score
Cellyan Biotechnology Co Ltd HKPD
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellyan Biotechnology Co Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Cellyan Biotechnology Co (HKPD) has a Insider Ownership of 0.00 % as of Sep. 12, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Cellyan Biotechnology Co and its competitors.
Is Cellyan Biotechnology Co's Insider Ownership too high?
Cellyan Biotechnology Co's current Insider Ownership is 0.00 %. Overall, Cellyan Biotechnology Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cellyan Biotechnology Co's Insider Ownership compare to COSM and YI?
Cellyan Biotechnology Co's Insider Ownership of 0.00 % can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Distribution company?
A good Insider Ownership depends on the Medical Distribution industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Cellyan Biotechnology Co and its competitors. Cellyan Biotechnology Co's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellyan Biotechnology Co stock overvalued right now?
Cellyan Biotechnology Co (HKPD) has a current Insider Ownership of 0.00 %. The current Insider Ownership is 0.00 %. Cellyan Biotechnology Co's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Cellyan Biotechnology Co (HKPD), the current Insider Ownership is 0.00 % as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellyan Biotechnology Co Business Description

Address 13 Ko Fai Road, Room B1, 5th Floor, Well Town Industrial Building, Yau Tong, Kowloon, Hong Kong, HKG
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
18GF Score

Get the complete analysis for HKPD

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price